. . . . . . . "[The moxibustion therapies (HPM and MWM) could reduce intestinal inflammation and restore intestinal epithelium barrier disruption in CD, which might be due to down-regulating TNF-?, TNFR1, and TNFR2 in intestinal mucosa and improving intestinal epithelium morphology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-01-25"^^ . . "Gene-disease associations inferred from animal model manually asserted gene-disease associations."@en . "DisGeNET evidence - PREDICTED"@en . "2017-10-17T13:16:49+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .